HOME >> MEDICINE >> NEWS
Studies demonstrate positive data in treatment of hepatitis C

BOSTON Data from two ongoing studies testing new approaches for the treatment of chronic hepatitis C will be presented at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) this afternoon.

Presented by principal investigator Nezam Afdhal, M.D., Chief of Hepatology at Beth Israel Deaconess Medical Center (BIDMC) and Associate Professor of Medicine at Harvard Medical School, the new findings provide researchers with sufficient evidence to demonstrate promising results for hepatitis C patients who have not responded to existing therapies.

A viral infection, hepatitis C is transmitted through exposure to infected blood. The virus, which affects an estimated 4 million individuals nationwide, is able to survive and flourish inside the body by taking up residence in the liver cells, and subsequently using the cells' inner machinery to make more copies of the virus. These in turn, infect other healthy cells.

The standard treatment for hepatitis C is a combination of interferon alfa and ribavirin, which act as anti-viral agents to eradicate the virus. According to Afdhal, the most recent advance in treatment has been the pegylation of interferon, which enables a once- a- week administration of the protein by injection and improves the ability to clear the virus. Combination therapy with pegylated interferon plus ribavirin for 24 to 48 weeks can result in eradication of the virus in about 50 percent of patients, he adds.

"When the hepatitis C virus doesn't respond as occurs in about half of all patients who are treated those patients who already have cirrhosis are at a far greater risk for developing liver cancer or suffering liver failure," notes Afdhal. In fact, he says, hepatitis C is the leading cause of liver transplants in the U.S. Until now, no treatment has been available for these patients.

In his first presentation, Afdhal will describe results from the COPILOT [Colchicine versus PEG-INTRON Long-Term
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
1-Nov-2004


Page: 1 2 3

Related medicine news :

1. Studies underscore genetic involvement in nicotine addiction & aggressive hostility
2. Studies address issues of risk and survival in rapidly increasing GI cancers
3. Studies examine coffee drinking and risk of liver and colorectal cancers
4. Studies reveal physicians attitudes on end-of-life care
5. Studies from the November issue of The Archives of Dermatology, a theme issue on facial rejuvenation
6. Studies link obesity to increased frequency of heartburn symptoms; greater risk of esophageal cancer
7. Studies examine risk factors and potential consequences associated with prehypertension
8. Studies show ACTOS(R) (pioglitazone HCl) has positive effects on various components of dyslipidemia
9. Studies identify risk factors for colon cancer
10. Studies indicate healthy eating may affect cancer development, improve digestive system
11. Studies compare hysterectomy vs. other medical treatments for abnormal uterine bleeding

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2019)... ... April 18, 2019 , ... It's time to try ... problem? Get to the root of the matter before those pesky dandruff flakes ... , Now you can attack dandruff before it attacks you. New ...
(Date:4/19/2019)... ... , ... The Patient Advocacy Community of The Beryl Institute ... NY with the 2019 Ruth Ravich Patient Advocacy Award in recognition of her ... Doyle was honored with the award at The Beryl Institute’s annual Patient Experience ...
(Date:4/18/2019)... ... 2019 , ... Arnet Pharmaceutical Corporation launched its Cognitive Support ... to support a healthy mind and body. The single and synergistic ingredients included ... The portfolio includes a total of ten products designed to cover the different ...
(Date:4/18/2019)... ... April 18, 2019 , ... The Coro Medical official sweepstakes grand prize winner ... , As a small, volunteer-only department in rural Mississippi, Livingston entered the national ... is the only department with life-saving equipment of this caliber in Panola County. , ...
(Date:4/17/2019)... ... April 17, 2019 , ... Historically, ... this reluctance appears to be changing. Whether because of demographic or generational changes, ... their healthcare providers advice. , In the past, efforts to publish performance data ...
Breaking Medicine News(10 mins):
(Date:4/19/2019)... ... April 18, 2019 , ... CBD Hacker , the definitive ... weekend 2019 . The list contains the best sales from brands that CBD Hacker’s ... will offer deep discounts on popular items. And CBD Hacker has also partnered with ...
(Date:4/18/2019)... ... 18, 2019 , ... ChronWell, a technology-enabled injury ... to participate in the inaugural “RIMS Tech, the Insurtech Competition” at RIMS ... 28th through May 1st. , The competition, which aims to award innovative ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... at the point-of-care, announces a new strategic partnership with Pharmacy Health Network ... now the exclusive sales and marketing representatives for PHN. , Together, the two ...
Breaking Medicine Technology:
Cached News: